Young Adults With Violent Behavior During Early Psychosis (Aim 2)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-19

Study Completion Date

2026-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to provide an evidence-based behavioral intervention to reduce violent behavior for individuals experiencing early psychosis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Improving Negative Symptoms of Psychosis In Real-world Environments

NCT02170051

Schizophrenia

COMPLETED NA

Social Cognitive Training for Psychosis: Treatment Development

NCT01579422

Schizophrenia Psychosis

COMPLETED PHASE1

Enhancing the Prospective Prediction of Psychosis

NCT00291200

Schizophrenia Psychotic Disorders

COMPLETED

Cognitive Behavioral Suicide Prevention for Psychosis: Aim 1

NCT04689867

Suicide Psychosis

COMPLETED NA

Psychosis: Early Detection, Intervention and Prevention

NCT01597141

Prodromal Schizophrenia Psychotic Disorders Severe Bipolar Disorder With Psychotic Features +1 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators will conduct an open pilot trial of a behavioral intervention to reduce violent behavior within the OnTrackNY network. The focus of this open pilot is to explore the acceptability and feasibility of the intervention. The study will enroll early intervention service (EIS) clinician - EIS participant dyads. The planned sample size is 3-4 EIS clinicians and 10-16 EIS participants (up to n=16 dyads). This real-world open pilot will provide feedback to help tailor the intervention to the OnTrackNY setting.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia Schizo Affective Disorder Schizophreniform Disorders Delusional Disorder Other Specified Schizophrenia Spectrum and Other Psychotic Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

open pilot clinical trial

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

behavioral intervention

This will involve conducting a 12-week open pilot trial (up to n=16 dyads of EIS clinicians-EIS participants) to test the feasibility and acceptability of the adapted Psychological Interventions for Coping with Anger and Schizophrenia: a study of outcomes (PICASSO) intervention in the OnTrackNY setting.

Group Type EXPERIMENTAL

adapted behavioral intervention

Intervention Type BEHAVIORAL

cognitive behavioral therapy based intervention that focuses on anger, violence, and psychosis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

adapted behavioral intervention

cognitive behavioral therapy based intervention that focuses on anger, violence, and psychosis

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

PICASSO

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ages 16 to 30 who have experienced nonaffective psychosis with a diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder, other specified/unspecified schizophrenia spectrum and other psychotic disorders (International Classification of Disease Clinical Modification (ICD-10-CM) Diagnosis Code F20.x)
* Receive First Episode Psychosis (FEP) treatment in one of OnTrackNY clinics/sites with an eligible EIS clinicians
* Willing to participate in research interviews after each study visit during the study period